About CompePharma

CompePharma is a daily news and analysis service on the business of pharma: deals and M&A, financing, approvals and launches, manufacturing and supply, pricing policy, legal disputes and quarterly earnings.

CompePharma is written for business development, commercial, finance, market-access and strategy professionals in pharma and biotech. Every story starts from a primary record (a regulator's website, an official journal, or a company filing with the US Securities and Exchange Commission), and every story links back to that record so readers can check it.

Who publishes CompePharma

CompePharma is published by PQRA, the regulatory, quality and pharmacovigilance consultancy of Dimitrios Gkikas, based in Marousi, Athens, Greece. PQRA has worked in pharmaceutical regulatory affairs, quality and pharmacovigilance for clients in Greece and Cyprus, and that experience decides what the site covers and how it explains it.

Our sister site VigiEye covers the regulatory side: approvals, pharmacovigilance, quality, guidelines and the PDUFA calendar.

How the site is funded

The news is free to read. The site is funded by advertising (Google AdSense), by its paid products, and by clearly labelled house advertisements for PQRA's consulting services. Advertisers have no influence on what we cover.

How stories are written

See our editorial policy for our sources, our use of AI tools and how to ask for a correction.